Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131824) titled 'the diagnostic value of combined detection of LRG1, VEGF, MCP-1, and KIM-1 in the early stage of diabetic nephropathy and its correlation with pathological characteristics' on Sept. 7.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Diabetic nephropathy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2023-01-01
Target Sample Size: Diabetic nephropathy observation group:120;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=288143
Published by HT Digital...